Loss of Epigenetic Kruppel-like Factor 4 Histone Deacetylase (KLF-4-HDAC)-mediated Transcriptional Suppression Is Crucial in Increasing Vascular Endothelial Growth Factor (VEGF) Expression in Breast Cancer-Reference-Cited by-同舟云学术

Loss of Epigenetic Kruppel-like Factor 4 Histone Deacetylase (KLF-4-HDAC)-mediated Transcriptional Suppression Is Crucial in Increasing Vascular Endothelial Growth Factor (VEGF) Expression in Breast Cancer

Published:2013-09 Issue:38 Volume:288 Page:27232-27242
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Ray Alpana,Alalem Mohamed,Ray Bimal K.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference71 articles.

1. Isolation of a tumor factor responsible for angiogenesis;Folkman;J. Exp. Med,1971

2. Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast;Engels;J. Pathol,1997

3. The role of vascular endothelial growth factor in pathological angiogenesis;Ferrara;Breast Cancer Res. Treat,1995

4. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications;Ferrara;Semin. Oncol,2002

5. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer;Yoshiji;Cancer Res,1996

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on existing therapeutic options and status of novel anti-metastatic agents in breast cancer: Elucidating the molecular mechanisms underlying the pleiotropic action of Withania somnifera (Indian ginseng) in breast cancer attenuation;International Immunopharmacology;2024-07

2. Histone modification and personalized epigenomics in cancer;Personalized Epigenetics;2024

3. A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression;Cancer Letters;2023-09

4. Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL);Clinical Epigenetics;2023-08-02

5. Krüppel-like factors in tumors: Key regulators and therapeutic avenues;Frontiers in Oncology;2023-01-25